| 1. Eguchi M, Shen RY, Shea JP, Lee MS, Kahn M.. (2002) Design, synthesis, and evaluation of opioid analogues with non-peptidic beta-turn scaffold: enkephalin and endomorphin mimetics., 45 (7): [PMID:11906279] [10.1021/jm0155897] |
| 2. Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ.. (2004) Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]., 47 (6): [PMID:14998329] [10.1021/jm030311v] |
| 3. Bartosz-Bechowski H, Davis P, Zalewska T, Slaninova J, Porreca F, Yamamura HI, Hruby VJ.. (1994) Cyclic enkephalin analogs with exceptional potency at peripheral delta opioid receptors., 37 (1): [PMID:8289188] [10.1021/jm00027a018] |
| 4. Froimowitz M, Pick CG, Pasternak GW.. (1992) Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity., 35 (9): [PMID:1315868] [10.1021/jm00087a004] |
| 5. Bertha CM, Flippen-Anderson JL, Rothman RB, Porreca F, Davis P, Xu H, Becketts K, Cha XY, Rice KC.. (1995) Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligands., 38 (9): [PMID:7739011] [10.1021/jm00009a013] |
| 6. Heyl DL, Mosberg HI.. (1992) Substitution on the Phe3 aromatic ring in cyclic delta opioid receptor-selective dermorphin/deltorphin tetrapeptide analogues: electronic and lipophilic requirements for receptor affinity., 35 (9): [PMID:1315870] [10.1021/jm00087a006] |
| 7. Grundt P, Jales AR, Traynor JR, Lewis JW, Husbands SM.. (2003) 14-amino, 14-alkylamino, and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profiles., 46 (8): [PMID:12672258] [10.1021/jm021073r] |
| 8. Haaseth RC, Horan PJ, Bilsky EJ, Davis P, Zalewska T, Slaninova J, Yamamura HI, Weber SJ, Davis TP, Porreca F.. (1994) [L-Ala3]DPDPE: a new enkephalin analog with a unique opioid receptor activity profile. Further evidence of delta-opioid receptor multiplicity., 37 (11): [PMID:8201592] [10.1021/jm00037a007] |
| 9. Salvadori S, Marastoni M, Balboni G, Borea PA, Morari M, Tomatis R.. (1991) Synthesis and structure-activity relationships of deltorphin analogues., 34 (5): [PMID:1851843] [10.1021/jm00109a019] |
| 10. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J.. (2003) Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery., 46 (9): [PMID:12699389] [10.1021/jm021012t] |
| 11. Qian X, Kövér KE, Shenderovich MD, Lou BS, Misicka A, Zalewska T, Horváth R, Davis P, Bilsky EJ, Porreca F.. (1994) Newly discovered stereochemical requirements in the side-chain conformation of delta opioid agonists for recognizing opioid delta receptors., 37 (12): [PMID:8021915] [10.1021/jm00038a004] |
| 12. Hruby VJ, Toth G, Gehrig CA, Kao LF, Knapp R, Lui GK, Yamamura HI, Kramer TH, Davis P, Burks TF.. (1991) Topographically designed analogues of [D-Pen,D-Pen5]enkephalin., 34 (6): [PMID:1648137] [10.1021/jm00110a010] |
| 13. Gacel G, Daugé V, Breuzé P, Delay-Goyet P, Roques BP.. (1988) Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for delta opioid receptors., 31 (10): [PMID:2845081] [10.1021/jm00118a005] |
| 14. Schmidhammer H, Stangl A, Furst Z, Szabo E, Borsodi A, Patel D, Traynor JR. (1995) Synthesis and biological evaluation of 14-alkoxymorphinans.12.1 A phenethyl analogue of the -selective opioid receptor antagonist cyprodime, 5 (17): [10.1016/0960-894X(95)00325-N] |
| 15. Schultz AG, Wang A, Alva C, Sebastian A, Glick SD, Deecher DC, Bidlack JM.. (1996) Asymmetric syntheses, opioid receptor affinities, and antinociceptive effects of 8-amino-5,9-methanobenzocyclooctenes, a new class of structural analogues of the morphine alkaloids., 39 (10): [PMID:8642554] [10.1021/jm950817g] |
| 16. Horikawa M, Shigeri Y, Yumoto N, Yoshikawa S, Nakajima T, Ohfune Y.. (1998) Syntheses of potent Leu-enkephalin analogs possessing beta-hydroxy-alpha,alpha-disubstituted-alpha-amino acid and their characterization to opioid receptors., 8 (15): [PMID:9873480] [10.1016/s0960-894x(98)00349-7] |
| 17. Bertha CM, Ellis M, Flippen-Anderson JL, Porreca F, Rothman RB, Davis P, Xu H, Becketts K, Rice KC.. (1996) Probes for narcotic receptor-mediated phenomena. 21. Novel derivatives of 3-(1,2,3,4,5,11-hexahydro-3-methyl-2,6-methano-6H-azocino[4,5-b]indol- 6-yl)-phenols with improved delta opioid receptor selectivity., 39 (10): [PMID:8642567] [10.1021/jm950695s] |
| 18. Calderon SN, Rothman RB, Porreca F, Flippen-Anderson JL, McNutt RW, Xu H, Smith LE, Bilsky EJ, Davis P, Rice KC.. (1994) Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist., 37 (14): [PMID:8035418] [10.1021/jm00040a002] |
| 19. Toth G, Russell KC, Landis G, Kramer TH, Fang L, Knapp R, Davis P, Burks TF, Yamamura HI, Hruby VJ.. (1992) Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity., 35 (13): [PMID:1320122] [10.1021/jm00091a006] |
| 20. Toth G, Kramer TH, Knapp R, Lui G, Davis P, Burks TF, Yamamura HI, Hruby VJ.. (1990) [D-Pen2,D-Pen5]enkephalin analogues with increased affinity and selectivity for delta opioid receptors., 33 (1): [PMID:2153205] [10.1021/jm00163a041] |
| 21. Portoghese PS, Moe ST, Takemori AE.. (1993) A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists., 36 (17): [PMID:8394935] [10.1021/jm00069a017] |
| 22. Shreder K, Zhang L, Dang T, Yaksh TL, Umeno H, DeHaven R, Daubert J, Goodman M.. (1998) Synthesis and biological activity of a novel methylamine-bridged enkephalin analogue (MABE): a new route to cyclic peptides and peptidomimetics., 41 (14): [PMID:9651168] [10.1021/jm970861r] |
| 23. Weerawarna SA, Davis RD, Nelson WL.. (1994) Isothiocyanate-substituted kappa-selective opioid receptor ligands derived from N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl] phenylacetamide., 37 (18): [PMID:8071934] [10.1021/jm00044a006] |
| 24. Thomas JB, Herault XM, Rothman RB, Burgess JP, Mascarella SW, Xu H, Horel RB, Dersch CM, Carroll FI.. (1999) (+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptor., 9 (20): [PMID:10571174] [10.1016/s0960-894x(99)00525-9] |
| 25. Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN, Lemieux C.. (1993) TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity., 36 (21): [PMID:8230106] [10.1021/jm00073a020] |
| 26. Thomas JB, Atkinson RN, Herault XM, Rothman RB, Mascarella SW, Dersch CM, Xu H, Horel RB, Carroll FI.. (1999) Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptor., 9 (23): [PMID:10612597] [10.1016/s0960-894x(99)00613-7] |
| 27. May EL, Aceto MD, Bowman ER, Bentley C, Martin BR, Harris LS, Medzihradsky F, Mattson MV, Jacobson AE.. (1994) Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties., 37 (20): [PMID:7932569] [10.1021/jm00046a026] |
| 28. Rew Y, Malkmus S, Svensson C, Yaksh TL, Chung NN, Schiller PW, Cassel JA, DeHaven RN, Taulane JP, Goodman M.. (2002) Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands., 45 (17): [PMID:12166947] [10.1021/jm020108k] |
| 29. Gacel G, Zajac JM, Delay-Goyet P, Daugé V, Roques BP.. (1988) Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides., 31 (2): [PMID:2828622] [10.1021/jm00397a019] |
| 30. Hruby VJ, Bartosz-Bechowski H, Davis P, Slaninova J, Zalewska T, Stropova D, Porreca F, Yamamura HI.. (1997) Cyclic enkephalin analogues with exceptional potency and selectivity for delta-opioid receptors., 40 (24): [PMID:9397176] [10.1021/jm9704762] |
| 31. Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.. (1996) The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors., 39 (20): [PMID:8831778] [10.1021/jm960078j] |
| 32. Hruby VJ.. (2003) Peptide science: exploring the use of chemical principles and interdisciplinary collaboration for understanding life processes., 46 (20): [PMID:13678399] [10.1021/jm0303103] |
| 33. Nelson TD, Davis RD, Nelson WL.. (1994) Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol., 37 (25): [PMID:7996538] [10.1021/jm00051a003] |
| 34. Portoghese PS, Larson DL, Sultana M, Takemori AE.. (1992) Opioid agonist and antagonist activities of morphindoles related to naltrindole., 35 (23): [PMID:1333013] [10.1021/jm00101a009] |
| 35. Mosberg HI, Kroona HB.. (1992) Incorporation of a novel conformationally restricted tyrosine analog into a cyclic, delta opioid receptor selective tetrapeptide (JOM-13) enhances delta receptor binding affinity and selectivity., 35 (23): [PMID:1333014] [10.1021/jm00101a030] |
| 36. Liao S, Alfaro-Lopez J, Shenderovich MD, Hosohata K, Lin J, Li X, Stropova D, Davis P, Jernigan KA, Porreca F, Yamamura HI, Hruby VJ.. (1998) De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor., 41 (24): [PMID:9822547] [10.1021/jm980374r] |
| 37. Davis RD, Nelson WL.. (1995) Isothiocyanate-substituted benzyl ether opioid receptor ligands derived from 6 beta-naltrexol., 38 (3): [PMID:7853350] [10.1021/jm00003a020] |
| 38. Landis G, Lui G, Shook JE, Yamamura HI, Burks TF, Hruby VJ.. (1989) Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group., 32 (3): [PMID:2537426] [10.1021/jm00123a023] |
| 39. Hansen DW, Stapelfeld A, Savage MA, Reichman M, Hammond DL, Haaseth RC, Mosberg HI.. (1992) Systemic analgesic activity and delta-opioid selectivity in [2,6-dimethyl-Tyr1,D-Pen2,D-Pen5]enkephalin., 35 (4): [PMID:1311764] [10.1021/jm00082a008] |
| 40. Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P, Horvath R.. (1997) Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands., 40 (5): [PMID:9057856] [10.1021/jm960319n] |
| 41. Husbands SM, Breeden SW, Grivas K, Lewis JW.. (1999) Ring constrained analogues of the orvinols: the furanomorphides., 9 (6): [PMID:10206545] [10.1016/s0960-894x(99)00085-2] |
| 42. Lee YS, Agnes RS, Badghisi H, Davis P, Ma SW, Lai J, Porreca F, Hruby VJ.. (2006) Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists., 49 (5): [PMID:16509592] [10.1021/jm050851n] |
| 43. Agnes RS, Lee YS, Davis P, Ma SW, Badghisi H, Porreca F, Lai J, Hruby VJ.. (2006) Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors., 49 (10): [PMID:16686530] [10.1021/jm050921q] |
| 44. Katavic PL, Venables DA, Rali T, Carroll AR.. (2007) Habbemines A and B, pyrrolidine alkaloids with human delta-opioid receptor binding affinity from the leaves of Elaeocarpus habbemensis., 70 (5): [PMID:17388627] [10.1021/np060577f] |
| 45. Katavic PL, Venables DA, Rali T, Carroll AR.. (2007) Indolizidine alkaloids with delta-opioid receptor binding affinity from the leaves of Elaeocarpus fuscoides., 70 (5): [PMID:17451272] [10.1021/np060607e] |
| 46. Yamamoto T, Nair P, Davis P, Ma SW, Navratilova E, Moye S, Tumati S, Lai J, Vanderah TW, Yamamura HI, Porreca F, Hruby VJ.. (2007) Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists., 50 (12): [PMID:17516639] [10.1021/jm061369n] |
| 47. Bernard D, Coop A, MacKerell AD.. (2007) Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity., 50 (8): [PMID:17367120] [10.1021/jm0612463] |
| 48. Katavic PL, Venables DA, Guymer GP, Forster PI, Carroll AR.. (2007) Alkaloids with human delta-opioid receptor binding affinity from the Australian rainforest tree Peripentadenia mearsii., 70 (12): [PMID:18039010] [10.1021/np070516x] |
| 49. Yamamoto T, Nair P, Vagner J, Largent-Milnes T, Davis P, Ma SW, Navratilova E, Moye S, Tumati S, Lai J, Yamamura HI, Vanderah TW, Porreca F, Hruby VJ.. (2008) A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists., 51 (5): [PMID:18266313] [10.1021/jm070332f] |
| 50. Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP.. (2008) Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity., 51 (14): [PMID:18588282] [10.1021/jm701575k] |
| 51. Lewin G, Le Ménez P, Rolland Y, Renouard A, Giesen-Crouse E.. (1992) Akuammine and dihydroakuammine, two indolomonoterpene alkaloids displaying affinity for opioid receptors., 55 (3): [PMID:1317407] [10.1021/np50081a017] |
| 52. Sakami S, Maeda M, Kawai K, Aoki T, Kawamura K, Fujii H, Hasebe K, Nakajima M, Endo T, Ueno S, Ito T, Kamei J, Nagase H.. (2008) Structure-antitussive activity relationships of naltrindole derivatives. Identification of novel and potent antitussive agents., 51 (15): [PMID:18637671] [10.1021/jm701440h] |
| 53. Yamamoto T, Nair P, Jacobsen NE, Davis P, Ma SW, Navratilova E, Moye S, Lai J, Yamamura HI, Vanderah TW, Porreca F, Hruby VJ.. (2008) The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists., 51 (20): [PMID:18821747] [10.1021/jm800389v] |
| 54. Guerrini R, Camarda V, Trapella C, Caló G, Rizzi A, Ruzza C, Fiorini S, Marzola E, Reinscheid RK, Regoli D, Salvadori S.. (2009) Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists., 52 (13): [PMID:19473027] [10.1021/jm900604g] |
| 55. Katavic PL, Venables DA, Forster PI, Guymer G, Carroll AR.. (2006) Grandisines C-G, indolizidine alkaloids from the Australian rainforest tree Elaeocarpus grandis., 69 (9): [PMID:16989522] [10.1021/np060179c] |
| 56. Yamamoto T, Nair P, Jacobsen NE, Vagner J, Kulkarni V, Davis P, Ma SW, Navratilova E, Yamamura HI, Vanderah TW, Porreca F, Lai J, Hruby VJ.. (2009) Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists., 52 (16): [PMID:20560643] [10.1021/jm900473p] |
| 57. Ghirmai S, Azar MR, Cashman JR.. (2009) Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation., 17 (18): [PMID:19683449] [10.1016/j.bmc.2009.07.069] |
| 58. Carroll AR, Arumugan T, Redburn J, Ngo A, Guymer GP, Forster PI, Quinn RJ.. (2010) Hasubanan alkaloids with delta-opioid binding affinity from the aerial parts of Stephania japonica., 73 (5): [PMID:20426456] [10.1021/np100009j] |
| 59. Yamamoto T, Nair P, Jacobsen NE, Kulkarni V, Davis P, Ma SW, Navratilova E, Yamamura HI, Vanderah TW, Porreca F, Lai J, Hruby VJ.. (2010) Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillamines., 53 (15): [PMID:20617791] [10.1021/jm100157m] |
| 60. Pasquinucci L, Prezzavento O, Marrazzo A, Amata E, Ronsisvalle S, Georgoussi Z, Fourla DD, Scoto GM, Parenti C, Aricò G, Ronsisvalle G.. (2010) Evaluation of N-substitution in 6,7-benzomorphan compounds., 18 (14): [PMID:20599386] [10.1016/j.bmc.2010.06.005] |
| 61. Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD.. (2008) cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia., 51 (22): [PMID:18983139] [10.1021/jm8007618] |
| 62. Lee YS, Kulkarani V, Cowell SM, Ma SW, Davis P, Hanlon KE, Vanderah TW, Lai J, Porreca F, Vardanyan R, Hruby VJ.. (2011) Development of potent μ and δ opioid agonists with high lipophilicity., 54 (1): [PMID:21128594] [10.1021/jm100982d] |
| 63. Majumdar S, Burgman M, Haselton N, Grinnell S, Ocampo J, Pasternak AR, Pasternak GW.. (2011) Generation of novel radiolabeled opiates through site-selective iodination., 21 (13): [PMID:21621410] [10.1016/j.bmcl.2011.05.008] |
| 64. Cami-Kobeci G, Polgar WE, Khroyan TV, Toll L, Husbands SM.. (2011) Structural determinants of opioid and NOP receptor activity in derivatives of buprenorphine., 54 (19): [PMID:21866885] [10.1021/jm2003238] |
| 65. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J.. (2003) Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery., 46 (9): [PMID:12699389] [10.1021/jm021012t] |
| 66. Cattori V, van Montfoort JE, Stieger B, Landmann L, Meijer DK, Winterhalter KH, Meier PJ, Hagenbuch B.. (2001) Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3., 443 (1): [PMID:11713643] [10.1007/s004240100697] |
| 67. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ.. (2000) Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier., 294 (1): [PMID:10871297] |
| 68. Dagenais C, Ducharme J, Pollack GM.. (2001) Uptake and efflux of the peptidic delta-opioid receptor agonist., 301 (1): [PMID:11257421] [10.1016/s0304-3940(01)01640-8] |
| 69. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B.. (2001) Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver., 120 (1): [PMID:11159893] [10.1053/gast.2001.21176] |
| 70. Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A.. (2003) Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin., 55 (1): [PMID:12906759] [10.1211/0022357021440] |
| 71. Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S.. (2001) LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers., 120 (1): [PMID:11375950] [10.1053/gast.2001.24804] |
| 72. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, Meier PJ.. (2002) Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter., 16 (1): [PMID:12351693] [10.1210/me.2001-0309] |
| 73. Vandormael B, Fourla DD, Gramowski-Voss A, Kosson P, Weiss DG, Schröder OH, Lipkowski A, Georgoussi Z, Tourwé D.. (2011) Superpotent [Dmt¹] dermorphin tetrapeptides containing the 4-aminotetrahydro-2-benzazepin-3-one scaffold with mixed μ/δ opioid receptor agonistic properties., 54 (22): [PMID:21978284] [10.1021/jm200894e] |
| 74. De Marco R, Tolomelli A, Spampinato S, Bedini A, Gentilucci L.. (2012) Opioid activity profiles of oversimplified peptides lacking in the protonable N-terminus., 55 (22): [PMID:22995061] [10.1021/jm301213s] |
| 75. Berezowska I, Lemieux C, Chung NN, Ding J, Schiller PW.. (2012) Novel TIPP (H-Tyr-Tic-Phe-Phe-OH) analogues displaying a wide range of efficacies at the δ opioid receptor. Discovery of two highly potent and selective δ opioid agonists., 22 (5): [PMID:22325949] [10.1016/j.bmcl.2012.01.063] |
| 76. Liu X, Wang Y, Xing Y, Yu J, Ji H, Kai M, Wang Z, Wang D, Zhang Y, Zhao D, Wang R.. (2013) Design, synthesis, and pharmacological characterization of novel endomorphin-1 analogues as extremely potent μ-opioid agonists., 56 (7): [PMID:23477419] [10.1021/jm400195y] |
| 77. Gao J, Radwan MM, León F, Dale OR, Husni AS, Wu Y, Lupien S, Wang X, Manly SP, Hill RA, Dugan FM, Cutler HG, Cutler SJ.. (2013) Neocosmospora sp.-derived resorcylic acid lactones with in vitro binding affinity for human opioid and cannabinoid receptors., 76 (5): [PMID:23659286] [10.1021/np300653d] |
| 78. Váradi A, Hosztafi S, Le Rouzic V, Tóth G, Urai Á, Noszál B, Pasternak GW, Grinnell SG, Majumdar S.. (2013) Novel 6β-acylaminomorphinans with analgesic activity., 69 [PMID:24103580] [10.1016/j.ejmech.2013.09.031] |
| 79. Hirayama S, Wada N, Kuroda N, Iwai T, Yamaotsu N, Hirono S, Fujii H, Nagase H.. (2014) Synthesis of a novel universal opioid receptor agonist with the 1,3,5-trioxazatriquinane skeleton and its pharmacologies., 24 (20): [PMID:25248680] [10.1016/j.bmcl.2014.08.012] |
| 80. De Marco R, Bedini A, Spampinato S, Gentilucci L.. (2014) Synthesis of tripeptides containing D-Trp substituted at the indole ring, assessment of opioid receptor binding and in vivo central antinociception., 57 (15): [PMID:25051243] [10.1021/jm5002925] |
| 81. Cheng MF, Ou LC, Chen SC, Chang WT, Law PY, Loh HH, Chao YS, Shih C, Yeh SH, Ueng SH.. (2014) Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists., 22 (17): [PMID:25087049] [10.1016/j.bmc.2014.07.012] |
| 82. Schmitt S, Colloc'h N, Perrio C.. (2015) Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies., 90 [PMID:25513968] [10.1016/j.ejmech.2014.12.016] |
| 83. Hu M, Giulianotti MA, McLaughlin JP, Shao J, Debevec G, Maida LE, Geer P, Cazares M, Misler J, Li L, Dooley C, Ganno ML, Eans SO, Mizrachi E, Santos RG, Yongye AB, Houghten RA, Yu Y.. (2015) Synthesis and biological evaluations of novel endomorphin analogues containing α-hydroxy-β-phenylalanine (AHPBA) displaying mixed μ/δ opioid receptor agonist and δ opioid receptor antagonist activities., 92 [PMID:25559207] [10.1016/j.ejmech.2014.12.049] |
| 84. Piekielna J, Perlikowska R, do-Rego JC, do-Rego JL, Cerlesi MC, Calo G, Kluczyk A, Łapiński K, Tömböly C, Janecka A.. (2015) Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalanines., 6 (5): [PMID:26005537] [10.1021/acsmedchemlett.5b00056] |
| 85. Kutsumura N, Nakajima R, Koyama Y, Miyata Y, Saitoh T, Yamamoto N, Iwata S, Fujii H, Nagase H.. (2015) Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound., 25 (21): [PMID:26099536] [10.1016/j.bmcl.2015.06.002] |
